ArticleAnnals of translational medicine2024
Insulin-producing cells derived from expandable stem cell-derived endoderm are effective for the treatment of type 2 diabetes.
Eiji YoshiharaPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.